Genomic classifier (ColoPrint) to predict outcome and chemotherapy benefit in stage II and III colon cancer patients.
Scott Kopetz
No relevant relationships to disclose
Zhi-Qin Jiang
No relevant relationships to disclose
Michael J. Overman
No relevant relationships to disclose
Robert Rosenberg
Research Funding - Agendia
Ramon Salazar
Research Funding - Agendia
Josep Tabernero
No relevant relationships to disclose
Lisette Stork
Employment or Leadership Position - Agendia
Ying Li
Employment or Leadership Position - Agendia
Iris Simon
Employment or Leadership Position - Agendia
George J. Chang
No relevant relationships to disclose
Dipen M. Maru
No relevant relationships to disclose